ACHILLES THERAPEUTICS PL-ADR (ACHL) Earnings History & Surprises
NASDAQ:ACHL • US00449L1026
1.48 USD
+0.01 (+0.68%)
Last: Mar 20, 2025, 08:00 PM
Past quarterly earnings results for ACHILLES THERAPEUTICS PL-ADR (ACHL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateApr 2, 2025
PeriodQ4 / 2024
EPS Estimate-$0.37
Revenue Estimate
Last Reported
Release DateNov 14, 2024
PeriodQ3 / 2024
EPS Reported-$0.48
EPS Surprise -14.78%
Revenue Surprise %
Beat Rate
19%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | -0.48 | -0.42 | -14.78% | -14.29% | - | - | ||
| Q2 2024 | -0.41 | -0.42 | 1.96% | 2.38% | - | - | ||
| Q1 2024 | -0.30 | -0.47 | 36.52% | 31.82% | - | - | ||
| Q4 2023 | -0.46 | -0.15 | -211.02% | 24.59% | - | - | ||
| Q3 2023 | -0.42 | -0.41 | -2.94% | -31.25% | - | - | ||
| Q2 2023 | -0.42 | -0.43 | 1.18% | 4.55% | - | - | ||
| Q1 2023 | -0.44 | -0.41 | -7.17% | 2.22% | - | - | ||
| Q4 2022 | -0.61 | -0.42 | -45.86% | -35.56% | - | - | ||
| Q3 2022 | -0.32 | -0.56 | 42.44% | 5.88% | - | - | ||
| Q2 2022 | -0.44 | -0.57 | 22.69% | 2.22% | - | - | ||
| Q1 2022 | -0.45 | -0.52 | 12.64% | 94.63% | - | - | ||
| Q4 2021 | -0.45 | -0.41 | -8.66% | - | - | - | ||
| Q3 2021 | -0.34 | -0.49 | 30.84% | - | - | - | ||
| Q2 2021 | -0.45 | -0.50 | 10.69% | - | - | - | ||
| Q1 2021 | -8.38 | -3.32 | -152.79% | - | - | - | ||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-46.83%
Max EPS beat (4)
36.52%
Min EPS beat (4)
-211.02%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, ACHL has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, ACHL reported -46.8% below the EPS estimates on average.
ACHILLES THERAPEUTICS PL-ADR / ACHL Earnings FAQ
What is the most recent earnings date for ACHL stock?
ACHILLES THERAPEUTICS PL-ADR (ACHL) last reported earnings on 11/14/2024.
Did ACHILLES THERAPEUTICS PL-ADR (ACHL) beat earnings estimates last quarter?
ACHILLES THERAPEUTICS PL-ADR (ACHL) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does ACHL stock beat earnings estimates?
In the last 4 quarters, ACHILLES THERAPEUTICS PL-ADR (ACHL) has beaten EPS estimates in 2 out of 4 releases.